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Abstract
Background: In this study, the biocompatibility, stability and osteotransductivity of a new cement based on alpha-
tricalcium phosphate (alpha-TCP) were investigated in a bone repair model using a rat model.
Methods: The potential of alpha-TCP on bone repair was compared to autogenous bone grafting, and unfilled cavities 
were used as negative control. Surgical cavities were prepared and designated as test (T), implanted with alpha-TCP 
blocks; negative control (C - ), unfilled; and positive control (C + ), implanted with autogenous bone graft. Results were 
analyzed on postoperative days three, seven, 14, 21 and 60.
Results: The histological analyses showed the following results. Postoperative day three: presence of inflammatory 
infiltrate, erythrocytes and proliferating fibroblasts in T, C - and C + samples. Day seven: extensive bone neoformation in 
groups T and C + , and beginning of alpha-TCP resorption by phagocytic cells. Days 14 and 21: osteoblastic activity in 
the three types of cavities. Day 60: In all samples, neoformed bone similar to surrounding bone. Moderate interruption 
on the ostectomized cortical bone.
Conclusions: Bone neoformation is seen seven days after implantation of alpha-TCP and autogenous bone. 
Comparison of C - with T and C + samples showed that repair is faster in implanted cavities; on day 60, control groups 
presented almost complete bone repair. Alpha-TCP cement presents biocompatibility and osteotransductivity, besides 
stability, but 60 days after surgery the cavities were not closed.
Background
Bone exists in two main structural types: primary bone
and lamellar or secondary bone [1]. Bone repair occurs in
a process that may take months or years [2]. The morpho-
logical and functional recovery of hard tissues lost during
the treatment of pathological processes and traumatic
lesions has been extensively studied, and different
approaches have been suggested.
A u t o g e n o u s  b o n e  g r a f t  i s  c o n s i d e r e d  t o  b e  t h e  g o l d
standard for replacement of lost tissue [3,4]. Garg, in
1999 [5], defined the three processes associated to the
fate of bone grafts: osteogenesis, osteoinduction and
osteoconduction. Osteogenesis is formation of bone,
whereas osteoinduction is the process by which osteo-
genesis is induced and osteoconduction is a physiologic
process whereby a conductor provides a physical matrix
for deposition of new bone tissue. Advancements in sur-
gical techniques to collect human bone for autogenous
grafting are not able to keep pace with the evolution in
the production of alloplastic material, such as calcium
phosphate cements [6], which have been successfully
used for bone repair in the last decade.
The ideal material must be biocompatible, bioactive
and resorbable [7]. Other desirable characteristics
include unlimited availability, stability and ability of fill-
ing and conformation [8]. Scaffold design is of primordial
importance for the success of bone tissue-engineering
grafts, and a wide variety of biomaterials, including poly-
mers, ceramics and composites) are under investigation
for bone repair (reviewed by Fröhlich et al. [9]). The asso-
ciation of biomaterials with stem/progenitor cells [10] or
their use as vehicles for cytokines, growth factors or
genes for bone formation [11] represent important addi-
tions to the field of regenerative medicine. Presently,
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however, no single biomaterial available for bone repair
and regeneration presents all the properties required for
an ideal bone graft (reviewed by [12]), and new combina-
tions of materials are under intensive research.
Brown and Chow (1986) [13] were the first to propose
the use of calcium phosphate cement in bone repair. Its
biocompatibility, bioactivity and osteoconductivity have
been shown in many studies [14-17], and its biological
behavior has been investigated in vivo [6,18]. In general,
these cements are absorbed by the intense activity of the
phagocytic system, leading to the simultaneous forma-
tion of new bone tissue in the interface bone/implant.
This process is called osteotransductivity [19]. Knabe et
al. [20] suggested that it is a slow process, which contin-
ues in average for two years after implantation. Toquet et
al. [21] analyzed the osteogenic potential of human bone
marrow cells during in vitro culture on calcium phos-
phate ceramics, showing that the cells populated the
pores of the material.
Santos, in 2002 [22], developed a new cement based on
alpha-tricalcium phosphate [Ca 3(PO 4) 2] (alpha-TCP) by
adding a fluid reducer, ammonium polyacrylate, to this
material. This new type of calcium phosphate showed
greater resistance to mechanical stress while maintaining
the characteristics of osteotransductivity and biocompat-
ibility. Considering the therapeutic potential of calcium
phosphate cements, the present work aimed to contribute
to this area of research by the histological analyses of the
effect of a new type of biomaterial, alpha-tricalcium
phosphate cement, as compared to autogenous bone
grafting, during bone repair in surgically created cavities.
Characteristics of alpha-TCP, such as biocompatibility,
stability and osteotransductivity were also investigated.
The study was conducted in a rat model, in which sur-
gical cavities were created according to the protocol
established by Puricelli [23,24]. The bone cavity has only
one ruptured cortical margin, allowing a type of fixation
of the bone fragments as an essential condition for the
production of a bone callus. Although more frequently
critical-sized bone defects of 5 mm are created to assess
healing progress in rats, smaller defects are also used.
Cao and Kuboyama [25], for instance, compared the ther-
apeutic potential of scaffolds composed of polyglycolic
acid and beta-tricalcium phosphate (PGA/β-TCP) or
hydroxylapatite, in a rat model in which 3 mm × 2 mm
femur defects were made. Studies conducted by our
group [19,20,26,27] have also shown that 2 mm × 4 mm
cavities, surgically induced on the cortical surface of the
femur, represent an adequate model to investigate the
role of different materials and processes on bone healing.
Methods
This controlled experimental study was conducted in the
Laboratory of Experimental Surgery of the Oral and Max-
illofacial Surgery and Traumatology Discipline, School of
Dentistry of Universidade Federal do Rio Grande do Sul
(UFRGS). The biomaterial used was produced in the
Department of Materials of the School of Mechanical
Engineering UFRGS. Thirty precured, cylindrical blocks
of alpha-tricalcium phosphate (alpha-TCP) with 2 mm
diameter and 4 mm length were produced. The material
was sterilized in hydrogen peroxide, following methods
established at Hospital de Clínicas de Porto Alegre
(HCPA, 2002) and Corsetti et al. [28].
Thirty 5-month old male Wistar rats were used, an age
at which sexual/social maturity is reached. The animals
were housed and maintained in accordance with the
guidelines for the care of laboratory animals, Normative
Resolution 04/97, prepared by the Ethics and Health
Research Committee/GPPG/HCPA. The project was
approved by the Research Ethics Committee of the
School of Dentistry of Universidade Federal do Rio
Grande do Sul.
The animals were anesthetized and the right hind leg
was shaved and the skin disinfected. A 3 cm incision was
made on the skin, the tissues were separated by layers and
the periosteum was incised with a scalpel. Surgical cavi-
ties were prepared on the cortical surface of the femur
with help of a perforated titanium surgical splint. Three
cavities were produced with a slow-rotation trephine bur,
under constant irrigation with physiological saline solu-
tion and aspiration. The cavities, measuring 2 mm wide
and 4 mm deep, were designated as test (T), negative con-
trol (C - ) and positive control (C + ), from proximal to
distal.
The ostectomized T cavities were filled with a precured
block of alpha-TCP. C + cavities received the bone frag-
ment removed from the T hole, whereas the C - cavities
were left without any filling (Figures 1 and 2). The wound
was sutured in layers (Vicryl - Ethicon, Johnson&John-
son, São José dos Campos, SP, Brazil).
The sample was randomly selected, with two control
and one experimental groups. The rats were divided into
five groups (n = 6 each), analyzed in different periods
after the experimental procedure: three, seven, 14, 21 and
60 postoperative days. The animals were euthanized, and
the right hind leg was stored in 10% neutral buffered for-
malin. The material included in paraffin was prepared
with a microtome, following the femoral long axis.
Sections were stained with hematoxylin and eosin, and
mounted with Canada balsam. Slides were analyzed with
an optical microscope (Model Lambda LQT 2, ATTO
Instruments Co., Hong Kong, China), with 40, 100, 250
and 400 magnification. Bone repair was qualitatively eval-
uated and compared among different groups.
This study is in accordance with the guidelines for ani-
mal research established by the State Code for AnimalPuricelli et al. Head & Face Medicine 2010, 6:10
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Protection and Normative Rule 04/97 from the Research
and Ethics in Health Committee/GPPG/HCPA.
Results
Representative results observed on the different postop-
erative days are presented in Figures 3, 4, 5, 6, 7 and 8
(days 3, 7, 14, 21 and 60, respectively). Within each group,
histological characteristics were described for each of the
surgical cavities. To evaluate the process of bone healing,
sections were analyzed for the amount of neoformed
bone, presence of an inflammatory infiltrate, and reaction
against a foreign body.
T cavity
All samples presented a marked regular interruption of
the ostectomized cortical bone, without dislocation of the
alpha-TCP block (Figure 3). On postoperative day 3, an
intense inflammatory infiltrate, erythrocytes and prolif-
erating fibroblasts were observed, but no bone neoforma-
tion (Figure 3). Evident bone neoformation, beginning on
the endosteum around the alpha-TCP block, along with
granulation tissue characterized by angiogenesis and
fiberplasia, were observed on day 7 (Figure 4). Irregulari-
ties could be seen on the border of the cement block, with
macrophages and giant multinucleated cells (Figure 5).
On postoperative day 14, the neoformation of trabecu-
lar bone was evidenced by the reversal (basophil) line, as
well as concentric cell areas with bone formation within
the block (Figure 6). On day 21, areas of bone tissue in
different maturation degrees were observed, with regres-
sion of the inflammatory activity and less fibrous tissue in
the region. The regularity of the implant-bone surface
interface was noteworthy (Figure 7). The marginal bone
neoformation was well organized, with bone isthmus
invasion and establishment in occasional irregularities of
the implanted inorganic structure. On day 60, mature
bone tissue replaced the immature tissue. The surface of
the alpha-TCP block was invaded by cells, and an outline
of neoformed bone surrounded the bone/implant inter-
face (Figure 8).
C - cavity
A markedly regular interruption of the ostectomized cor-
tical bone was observed in all samples. Three days after
the surgery, no bone neoformation was observed. An
inflammatory infiltrate and intense fibroblastic prolifera-
tion were seen in the medullary space. The fiberplasia
process, started in the periosteum, showed invagination
towards the cavity (Figure 3). The medullary tissue sur-
rounding the cavity had altered continuity and was rich in
megakariocytes. Seven days after surgery, intense fiber-
Figure 1 Intraoperative aspect of the C - cavity (no implantation). 
T and C + cavities are already implanted. The proximal (P) and distal (D) 
endings are identified.
Figure 2 Test (T), negative control (C - ) and positive control (C + ) 
cavities on the femur.Puricelli et al. Head & Face Medicine 2010, 6:10
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plasia was seen, and no bone neoformation (Figure 4).
Erythrocytes, moderate angiogenesis and an inflamma-
tory infiltrate were observed in the medullary compart-
ment. On day 14, the samples showed bone
neoformation, of a predominantly endosteal nature,
blocking the interruption between the cortical areas, and
reduced levels of inflammatory infiltrate and fibrous tis-
sue (Figure 6). On day 21, the cortical organization could
be seen by the presence of trabecular projections, with
maturation of lamellar bone whose thickness was com-
patible with the original bone structure of the region (Fig-
ure 7). The ordered presence of adipocytes in the bone
marrow showed that the hematopoietic tissue was
mature. On Day 60, there was a small indent in the cortex
suggestive of wound healing (Figure 8). The dimension
and cellular aspect of the medullary channel returned to
normal conditions.
Figure 3 Histological aspects of samples collected three days after surgery. A, T cavity, The implanted alpha-tricalcium phosphate (alpha-TCP) 
can be observed inside the bone cavity. The cortical floor is preserved. (Magnification 40×). B, C - cavity, with no implantation. Important fiberplasia in 
the region. (Magnification 40×). C, C + cavity, The bone graft is horizontally placed in the cavity. (Magnification 40×).
Figure 4 Histological aspects of samples collected seven days after surgery. A, T cavity, The stability of the alpha-tricalcium phosphate (alpha-
TCP) block implanted in the bone cavity can be observed. (Magnification 40×). B, C - cavity, The implant-free cavity shows import fiberplasia. Bone 
fragments may be seen in the interior. (Magnification 40×). C, C + cavity, The bone graft (BG) can be seen as two superimposed segments. (Magnifi-
cation 40×).Puricelli et al. Head & Face Medicine 2010, 6:10
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C + cavity
A markedly regular interruption in the ostectomized cor-
tical bone was observed in all samples. On day 7, acceler-
ated bone neoformation was observed (Figure 4). On day
14, primary bone tissue and osteoblastic cells were seen
(Figure 6). The reversal line (basophil line) was also
observed between the lamellar and primary bone tissues.
The hematopoietic bone marrow showed a tendency
towards a normal aspect. On postoperative day 21, the
upper surface of the cavity presented bone tissue in dif-
ferent degrees of maturation and osteoblasts which
merged its structure with that of the graft surface (Figure
7). On day 60, progressive bone neoformation induced by
osteoblasts was seen, as well as bone repair confirmed by
the closure of the cortical bone (Figure 8).
Discussion
The experimental protocol used in this work, established
by Puricelli and colleagues [23,24,26,27], has proven very
adequate for this type of study. The ostectomized cortical
structure showed marked regularity, in all groups and
experimental periods investigated. Three and 7 days after
surgery, all samples showed the presence of granulation
tissue in the cavities, previously described by Junqueira
and Carneiro [29] and Burkitt et al. [1].
Figure 5 Histological analysis of the T cavity, in samples collected on postoperative day seven. A, alpha-tricalcium phosphate (alpha-TCP) 
block within the cavity. A gap (G) is seen, probably caused by resorption of the material. (Magnification 100×). B, gap in the cement block, caused by 
activity of the phagocytic system. (Magnification 400×).
Figure 6 Histological aspects of samples collected on postoperative day 14. A, T cavity, Alpha-tricalcium phosphate (alpha-TCP) block implanted 
in the bone cavity. The material shows irregularities on its surface and interior, evidencing bone neoformation. (Magnification 40×). B, C - cavity, OR In 
the graft-free cavity, leveling of trabecular bone prevents the closure of the bone wound. (Magnification 40×). C, C + cavity, The grafted segments drift 
apart, but keep parallel orientation. Extensive fibrosis is observed between the bone grafts. (Magnification 40×).Puricelli et al. Head & Face Medicine 2010, 6:10
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The biological properties of autogenous bone grafting,
considered to be the gold standard [3-5], could be
observed seven days after surgery, with an accelerated
process of bone neoformation, as compared to the nega-
tive control group. The present study also showed that
alpha-TCP blocks filled the surgical cavities without the
development of inflammatory reactions of significant
extension or duration, as already shown in other studies
[16,17].
In the present work, we used histological parameters to
monitor the process of bone healing. The progress of
fracture healing is often difficult to assess, and clinicians
have to rely on subjective parameters such as pain or ten-
derness to palpation to monitor this process. A consistent
Figure 7 Histological aspects of samples collected on postoperative day 21. A, T cavity, The alpha-tricalcium phosphate (alpha-TCP) block occu-
pies all the bone cavity. The regular margins of the cavity contrast with the irregular surface of the material. (Magnification 40×). B, C - cavity, Continued 
healing of the cortex, in the upper surface of the surgical cavity. The medullary channel shows progressively increasing regularization. (Magnification 
40×). C, C + cavity, The bone graft (BG) is seen in continuity with the trabecular area, which is merging into cortical bone. (Magnification 40×).
Figure 8 Histological aspects of samples collected on postoperative day 60. A, T cavity, The alpha-tricalcium phosphate (alpha-TCP) block is in 
almost completely surrounded by mature bone tissue. (Magnification 40×). B, C - cavity, Well advanced process of bone healing and remodeling, in-
dicating return to normal of the ostectomized region (Magnification 40×). C, C + cavity, Occlusion of the roof of the ostectomized cavity, with integra-
tion of great part of the bone graft (BG) with the cortical bone. (Magnification 40×).Puricelli et al. Head & Face Medicine 2010, 6:10
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definition of bone healing is lacking (reviewed by [30]),
and many biological markers which are easy to assess on
radiographic examination have shown poor correlation
with mechanical strength [31]. More recently developed
methods, such as micro-computed tomography (micro-
CT [33] or structural rigidity analysis [31], have shown
potential in monitoring the progression of fracture heal-
ing over time. Histological analysis, however, is still con-
sidered a valuable tool to asses fracture healing, and has
shown good correlation with quantitative methods. In a
study aiming to evaluate the role of endothelial progeni-
tor cells on bone regeneration in a rat model, healing was
evaluated with radiographic, histological, and micro-CT
scans [34]. Histological results, showing that cell-treated
animals had significantly higher levels of new bone and
vessel formation than controls, correlated with radio-
graphic and micro-CT assessments showing significantly
improved parameters of bone volume, density, trabecular
number, thickness and spacing, as well as bone surface
and bone surface to bone volume ratio for the treated
group compared to control.
According to Schenk et al. [7], the ideal biomaterial
should show resorption during the remodeling phase,
being replaced by bone tissue. These histological results
support previous studies by Parker (1995) [19] showing
that, simultaneous to bone neoformation in the bone/
implant interface, the cement is phagocytosed by mac-
rophages and multinucleated giant cells, adding
osteotransductivity to its properties. Cavities filled with
the alpha-TCP cement showed, as early as seven days
after surgery, accelerated bone neoformation, surround-
ing the cement blocks. On day 14, concentric cellular
areas with bone formation were observed in the interior
of the blocks. Similar results were reported by Toquet et
al. [21].
In a meta-analysis of histomorphometry and graft heal-
ing time of different types of biomaterials used as sinus
floor augmentation material in humans, Klijn et al. [35]
concluded that autologous bone is still the gold standard.
Allogenic, xenogenic or alloplastic graft materials
resulted in a significantly lower amount of bone volume
as compared to autologous bone grafting. However, a
wide variety of scaffolds have shown therapeutic results
on the repair of bone defects. Gunatillake and Adhikari
[36] reviewed the role of biodegradable synthetic poly-
mers in bone healing, showing their potential in many
types of clinical applications. The therapeutic potential of
PGA/β-TCP was studied in a rat model [25]. The scaffold
presented strong ability for osteogenesis, mineralization
and biodegradation for bone replacement.
The alpha-TCP cement formulated by Santos (2002)
[22] has the stability property proposed by Shindo et al.
[8] as important for biomaterials. Our results showed
that, in all groups, bone neoformation involved initially
the formation of immature primary bone that was pro-
gressively remodeled for production of mature lamellar
bone. This process is well known in humans, as described
by Burkitt, Young and Heath (1994) [1] and Junqueira and
Carneiro (2004) [29]. The design used in the present
study did not allow for the investigation of a role for the
periosteum in this process. The importance of the perios-
teum for nutrition of the augmentation area during bone
healing has been already described [37]. Due to this activ-
ity, which seems to be induced by Bone Morphogenetic
Proteins (BMPs) [38], surgeons try to preserve the perios-
teum while treating bone defects.
Sixty days after surgery, a slight interruption of the
ostectomized cortical bone could be seen in C - and C +
cavities, whereas in the T cavities there was no occlusion
on the cavity roof. As already pointed by Schilling et al.
[2], the bone repair process may take months to years to
be completed. Resorption of calcium phosphate cements
is slow, and the biomaterial may last for up to two years
after implantation [20].
The present study evidenced the osteoconductivity
property of calcium phosphate cements, that induced
vigorous trabecular formation, as already indicated in
several reports [6,11,17,18,23].
Conclusion
The histologic results of the present study show that, in
rats, the alpha-tricalcium phosphate [Ca 3(PO 4) 2] devel-
oped by Santos (2002) [22] presents the properties of bio-
compatibility, osteotransductivity and stability. The
repair process was initially faster in filled (T and C + )
cavities than in non-implanted (C - ) cavities. The results
suggest that the analysis of resorption of this cement
should be performed in periods longer than 60 days after
surgery.
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